Form 4 Filing for Editas Medicine, Inc.

This filing details a Form 4 submission for Editas Medicine, Inc. (EDIT) by Ory Daniel Scott, the EVP, Chief Medical Officer. On September 8, 2026, Mr. Scott was granted 950,000 stock options with a right to buy at a price of $0.00 per share. These options are for the company's Common Stock. The options are set to expire on September 7, 2036. Vesting is scheduled over four years, starting with 25% on October 15, 2027, and the remaining 75% vesting in equal monthly installments through October 15, 2030. The conversion or exercise price is noted as $3.03. Following this transaction, Mr. Scott owns 950,000 shares.